MedTrace Logo

Characterization of Abdomino-pelvic Lesions by 18Fluorine- Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography

NCT07127627 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 79

Last updated 2025-08-17

No results posted yet for this study

Summary

The aim of the study is to identify and characterize lesions in the abdominopelvic region detected by 18fluorine- fluorodeoxyglucose (FDG) positron Emission Tomography combined Computed Tomography (PET/CT) scan, including determining their malignant or benign nature, and to determine the extent of disease to facilitate proper management

Conditions

  • Abdominal Sepsis

Interventions

DEVICE

PET/CT

positron emission tomography/computed tomography

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-31
Primary Completion
2028-10-31
Completion
2028-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07127627 on ClinicalTrials.gov